American Journal of Kidney Diseases
Volume 51, Issue 4 , Pages 573-583 , April 2008

Association of Analgesic Use With Prevalence of Albuminuria and Reduced GFR in US Adults

  • Lawrence Y. Agodoa, MD

      Affiliations

    • Division of Kidney, Urologic, and Hematologic Disorders, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD
    • Corresponding Author InformationAddress correspondence to Lawrence Y. Agodoa, MD, National Institute of Diabetes and Digestive and Kidney Diseases, 6707 Democracy Blvd, Rm 611, Bethesda, MD 20892-5458.
    • ,
  • Mildred E. Francis, ScD

      Affiliations

    • Social & Scientific Systems Inc., Silver Spring, MD.
    • ,
  • Paul W. Eggers, PhD

      Affiliations

    • Division of Kidney, Urologic, and Hematologic Disorders, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD

Received 23 May 2007 ,Accepted 11 December 2007.

References 

  1. Henrich WL, Clark RL, Kelly JP, et al. Non-contrast-enhanced computerized tomography and analgesic-related kidney disease: Report of the National Analgesic Nephropathy Study. J Am Soc Nephrol. 2006;17:1472–1480
  2. Mihatsch MJ, Khanlari B, Brunner FP. Obituary to analgesic nephropathy—An autopsy study. Nephrol Dial Transplant. 2006;21:3139–3145
  3. Henrich WL, Agodoa LE, Barrett B, et al. Analgesics and the kidney: Summary and recommendations to the Scientific Advisory Board of the National Kidney Foundation from an Ad Hoc Committee of the National Kidney Foundation. Am J Kidney Dis. 1996;27:162–165
  4. Ad Hoc Committee of the International Study Group on Analgesics and Nephropathy. Relationship between nonphenacetin combined analgesics and nephropathy: A review. Kidney Int. 2000;58:2259–2264
  5. McLaughlin JK, Lipworth L, Chow W, Blot WJ. Analgesic use and chronic renal failure: A critical review of the epidemiological literature. Kidney Int. 1998;54:679–686
  6. Delzell E, Shapiro S. A review of epidemiologic studies of nonnarcotic analgesics and chronic renal disease. Medicine. 1998;77:102–121(Baltimore)
  7. Rexrode KM, Buring JE, Glynn RJ, et al. Analgesic use and renal function in men. JAMA. 2001;286:315–321
  8. Curhan GC, Knight EL, Rosner B, et al. Lifetime nonnarcotic analgesic use and decline in renal function in women. Arch Intern Med. 2004;164:1519–1524
  9. Paulose-Ram R, Hirsch R, Dillon C, Gu Q. Frequent monthly use of selected non-prescription and prescription non-narcotic analgesics among US adults. Pharmacoepidemiol Drug Safety. 2005;14:257–266
  10. MacNeil ML, Mueller PW, Caudill SP, Steinberg KK. Considerations when measuring urinary albumin: Precision, substances that may interfere, and conditions for sample storage. Clin Chem. 1991;37:2120–2123
  11. Innanen VT, Groom BM, de Campos FM. Microalbuminuria and freezing. Clin Chem. 1997;43:1093–1094
  12. Chavers BM, Simonson J, Michael AF. A solid-phase fluorescent immunoassay for the measurement of human urinary albumin. Kidney Int. 1984;25:576–578
  13. Fabiny DL, Ertingshausen G. Automated reaction-rate method for determination of serum creatinine with CentrifiChem. Clin Chem. 1971;17:696–700
  14. National Center for Health Statistics. 1999-2000 NHANES Analytic Note. Available at http://www//cdc/gov/nchs/frequency/lab18_doc.pdf. 2001-2002 NHANES Analytic Note. Available at: http://www.cdc.gov/nchs/data/nhanes/nhanes_01_02/l40_b_doc.pdf. Accessed January 8, 2007
  15. Levy AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247–254
  16. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States (The Slone Survey). JAMA. 2002;287:337–344
  17. Murray TG, Stolley PD, Anthony J, et al. Epidemiologic study of regular analgesic use and end-stage renal disease. Arch Intern Med. 1983;143:1687–1693
  18. Sandler DP, Smith JC, Weinberg CR, et al. Analgesic use and chronic renal disease. N Engl J Med. 1989;320:1238–1243
  19. Perneger TV, Whelton PK, Klag MJ. Risk of kidney failure associated with use of acetaminophen, aspirin and NSAIDs. N Engl J Med. 1994;331:1675–1679
  20. Fored CM, Ejerblad E, Linblad P, et al. Acetaminophen, aspirin and chronic renal failure. N Engl J Med. 2001;345:1801–1808
  21. Ibanez L, Morlans M, Vidal X, Martinez MJ, Laporte J. Case-control study of regular analgesic and nonsteroidal anti-inflammatory use and end-stage renal disease. Kidney Int. 2005;67:2393–2398
  22. Murray MD, Brater DC, Tierney WM, Hui SL, McDonald CJ. Ibuprofen-associated renal impairment in a large general internal medicine practice. Am J Med Sci. 1990;299:222–229
  23. Sandler DP, Burr FR, Weinberg CR. Nonsteroidal anti-inflammatory drugs and the risk for chronic renal disease. Ann Intern Med. 1991;115:165–172
  24. Kurth T, Glynn RJ, Walker AM, et al. Analgesic use and change in kidney function in apparently healthy men. Am J Kidney Dis. 2003;42:234–244
  25. Mogensen CE, Vittinghus E, Solling K. Abnormal albumin excretion after two provocative renal tests in diabetes: Physical exercise and lysine injection. Kidney Int. 1979;16:385–393
  26. Viberti GC, Mogensen CE, Keen H, Jacobsen FK, Jarrett RJ, Christensen CK. Urinary excretion of albumin in normal man: The effect of water loading. Scand J Clin Lab Invest. 1982;42:147–157
  27. Basi S, Lewis JB. Microalbuminuria as a target to improve cardiovascular and renal outcomes. Am J Kidney Dis. 2006;47:927–946
  28. Levy AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med. 1999;130:461–470
  29. Preiss DJ, Godber IM, Gunn IR. Eating cooked meat alters serum creatinine concentration and eGFR. BMJ. 2006;333:1072
  30. Kaysen GA, Gambertoglio J, Jimenez J, Jones H, Hutchinson FN. Effects of dietary protein intake on albumin: Homeostasis in nephrotic patients. Kidney Int. 1986;29:572–577
  31. Coresh J, Byrd-Holt D, Astor BC, et al. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol. 2005;16:180–188
  32. Saydah S, Eberhardt M, Rios-Burrows N, Williams D, Geiss L, Dorsey R. Prevalence of chronic kidney disease and associated risk factors—United States 1999-2004. MMWR Morbid Mortal Wkly Rep. 2007;56:161–165
  33. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003;41:1–12
  34. Ericksen BO, Ingerbretsen OC. In chronic kidney disease staging the use of the chronicity criterion affects prognosis and the rate of progression. Kidney Int. 2007;72:1242–1248
  35. Ishani A, Grandits GA, Grimm RH, et al. Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the Multiple Risk Factor Intervention Trial. J Am Soc Nephrol. 2006;17:1444–1452
  36. Wang TJ, Gona P, Larson MG, et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med. 2006;355:2631–2639
  37. Heerspink HJL, Brinkman JW, Bakker SJL, Gansevoort RT, de Zeeuw D. Update on microalbuminuria as a biomarker in renal and cardiovascular disease. Curr Opin Nephrol Hypertens. 2006;15:631–636

 Originally published online as doi:10.1053/j.ajkd.2007.12.014 on February 27, 2008.

PII: S0272-6386(08)00002-4

doi: 10.1053/j.ajkd.2007.12.014

American Journal of Kidney Diseases
Volume 51, Issue 4 , Pages 573-583 , April 2008

Article Tools